Metraipolis › archive › dc_cecca3989433
Autologous whole blood clot formation with actigraft in patients receiving oral anticoagulant therapy: an ex vivo feasibility study — Europe PMC PMID:42177743
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42177743
- DOI
- 10.1007/s11239-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T08:47:54.863Z
- SHA-256 of the archived text
7fca855154c75d6e5c9d8b59fb6f195d502f2e1092b20d50f89c61669c318597- Stable URL of this page
https://metraipolis.com/documento/dc_cecca3989433
How to cite
Autologous whole blood clot formation with actigraft in patients receiving oral anticoagulant therapy: an ex vivo feasibility study — Europe PMC PMID:42177743 — Europe PMC (en), https://europepmc.org/article/MED/42177743 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cecca3989433 (Metraipolis archive dc_cecca3989433, sha256 7fca855154c75d6e5c9d8b59fb6f195d502f2e1092b20d50f89c61669c318597)
BibTeX
@misc{dccecca3989433,
title = {Autologous whole blood clot formation with actigraft in patients receiving oral anticoagulant therapy: an ex vivo feasibility study — Europe PMC PMID:42177743},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42177743},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cecca3989433; sha256 7fca855154c75d6e5c9d8b59fb6f195d502f2e1092b20d50f89c61669c318597},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42177743. Agents can read the archived copy with the MCP tool read_document.